drugset / Trial / NCT03649334

Ketamine-ketorolac Versus Fentanyl- Ketorolac I.M in Children During Bone Marrow Biopsy

NCT03649334

Phase 4 Completed 80 enrolled Mansoura University
RandomizedParallel-groupDouble-blindOther

Summary

investigators aim to compare between anaesthetic regimens that included dual-agent (fentanyl and ketorolac) or (ketamine and ketorolac) analgesic therapy

Timeline

Start
2018-08-26
Primary completion
2018-10-01
Completion
2018-10-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Fentanyl Other / unclassified 1.5 ug/kg Intramuscular
Subject Ketamine Small molecule 0.5 mg/kg Intramuscular
Background Ketorolac Other / unclassified 1 mg/kg Intramuscular